Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 37.69% is 52% below its 5-year average of 78.18%, near the low end of its 5-year range (0.00%–211.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.06% above its 12-month average of 36.92%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.69%.
DEBT TO ASSETS RATIO
37.69%
DEBT TO ASSETS RATIO AVG TTM
36.92%
DEBT TO ASSETS RATIO AVG 3Y
70.49%
DEBT TO ASSETS RATIO AVG 5Y
78.18%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.06%
CURRENT VS 3Y AVG
-46.54%
CURRENT VS 5Y AVG
-51.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+41772.73%
vs the sector median at left
Scilex Holding Company
Market Cap
$33.58M
Debt to Assets Ratio
37.69%
TTM Avg
36.92%
3Y Avg
70.49%
5Y Avg
78.18%
Market Cap
$33.33M
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.60M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.42M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.17M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.77M
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.06M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $33.58M | 37.69% | 36.92% | 70.49% | 78.18% |
| Accuray Incorporated (ARAY)vs › | $33.33M | 0.41% | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.60M | 0.05% | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.93M | 0.00% | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.04M | 0.25% | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | 0.00% | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $32.17M | 0.25% | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 0.22% | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | 0.00% | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.62M | 0.14% | N/A | N/A | N/A |
Debt/Assets
37.7%
Debt/Equity
N/A
Current Ratio
0.07
Interest Coverage
-23.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 37.69% |
| 2026-03-31 | 36.22% |
| 2025-12-31 | 36.32% |
| 2025-09-30 | 24.53% |
| 2025-06-30 | 49.87% |
| 2025-03-31 | 52.56% |
| 2024-12-31 | 40.84% |
| 2024-09-30 | 100.94% |
| 2024-06-30 | 102.35% |
| 2024-03-31 | 122.80% |
| 2023-12-31 | 126.80% |
| 2023-09-30 | 155.65% |
| 2023-06-30 | 29.83% |
| 2023-03-31 | 12.59% |
| 2022-12-31 | 1.63% |
| 2022-09-30 | 125.49% |
| 2022-06-30 | 211.21% |
| 2022-03-31 | 175.86% |
| 2021-12-31 | 198.57% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 170.09% |
| 2020-09-30 | 167.54% |
| 2020-06-30 | 167.54% |
| 2020-03-31 | 167.54% |
